You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for HEPARIN SOD


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HEPARIN SOD

Average Pharmacy Cost for HEPARIN SOD

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HEPARIN SODIUM 10,000 UNIT/ML VIAL 00641-0410-12 2.15001 ML 2025-01-22
HEPARIN SODIUM 10,000 UNIT/ML VIAL 25021-0403-66 2.15001 ML 2025-01-22
HEPARIN SODIUM 10,000 UNIT/ML VIAL 63323-0542-13 2.15001 ML 2025-01-22
HEPARIN SODIUM 10,000 UNIT/ML VIAL 25021-0403-01 2.15001 ML 2025-01-22
HEPARIN SODIUM 5,000 UNIT/ML VIAL 81952-0111-06 1.27452 ML 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for HEPARIN SOD

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
HEPARIN SODIUM 5000IU/ML (PF) SYR Hikma Pharmaceuticals USA Inc. 00641-6199-10 10X1ML 36.13 2021-08-15 - 2026-08-14 Big4
HEPARIN SODIUM 5000IU/ML (PF) SYR Hikma Pharmaceuticals USA Inc. 00641-6199-10 10X1ML 51.56 2021-08-15 - 2026-08-14 FSS
HEPARIN SODIUM 1,000 UNIT/ML VIAL Hikma Pharmaceuticals USA Inc. 00641-0391-12 25X1ML 9.66 2021-08-15 - 2026-08-14 Big4
HEPARIN SODIUM 5000IU/ML (PF) SYR Hikma Pharmaceuticals USA Inc. 00641-6199-10 10X1ML 36.94 2022-01-01 - 2026-08-14 Big4
HEPARIN SODIUM 1,000 UNIT/ML VIAL Hikma Pharmaceuticals USA Inc. 00641-0391-12 25X1ML 58.30 2021-08-15 - 2026-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Heparin Sodium

Market Size and Forecast

The global Heparin Sodium market is experiencing significant growth, driven by several key factors. As of 2024, the market size was valued at USD 5.76 billion and is projected to reach USD 9.72 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period[1][2].

Global Heparin Sodium Market Drivers

Several factors are driving the growth of the Heparin Sodium market:

  • Rising Prevalence of Cardiovascular Diseases: The increasing prevalence of cardiovascular disorders, which often require anticoagulant treatments, is a major driver. Heparin sodium is commonly used in the treatment and prevention of thromboembolic events linked to these diseases[1].
  • Advancements in Drug Delivery and Production: Improvements in drug delivery methods and pharmaceutical production processes are enhancing the safety and effectiveness of heparin sodium formulations, leading to better patient outcomes and higher product quality[1].
  • Growing Healthcare Expenditure: Increasing healthcare spending, particularly in emerging nations, is making modern medical therapies like heparin sodium more accessible. This trend is expected to support market expansion in these regions[1].
  • Regulatory Support and Approval: Strict guidelines and regulatory approvals for novel formulations and indications ensure the safety and quality of heparin sodium products, further aiding market growth[1].

Challenges and Restraints

Despite the growth drivers, the market faces several challenges:

  • Safety Concerns: Heparin-induced thrombocytopenia (HIT) and allergic reactions are significant safety concerns that may reduce the usage of heparin sodium in certain patient populations[1].
  • Price Volatility: Fluctuations in the cost of raw materials, such as pig mucosa, can impact manufacturers' profit margins and market pricing[1].
  • Competition from Generic Manufacturers: The expiration of patents on some heparin sodium formulations has led to increased competition from generic producers, which can drive down prices and limit revenue for branded products[1].

Geographical Analysis

The global Heparin Sodium market is segmented geographically into North America, Europe, Asia Pacific, and the Rest of the World.

  • North America: Expected to hold the largest market share during the forecast period, driven by significant players and increased investments in research and development[1].
  • Europe: A substantial market due to the presence of major healthcare infrastructure and high demand for anticoagulant treatments.
  • Asia Pacific: Growing rapidly due to increasing healthcare expenditure and a rising prevalence of cardiovascular diseases in countries like China, Japan, and India[1].

End-User Segmentation

The market is also segmented based on end-users, with hospitals dominating the segment due to the high demand for heparin sodium in these settings[3].

Price Projections and Trends

The prices of heparin sodium products vary widely based on concentration, formulation, and volume.

  • Injectable Solutions: Prices range from $70.70 for 10 milliliters of 5000 units/mL solution to $239.48 for 6000 milliliters of 100 units/mL solution[5].
  • Intravenous Solutions: Prices vary from $20.15 for 500 milliliters of 50 units/mL solution to $353.66 for 12000 milliliters of 40 units/mL solution[5].

Heparin Sodium Tubes Market

The market for heparin sodium tubes, used for blood collection and diagnostic tests, is also growing:

  • Increasing Demand for Blood Tests: Rising prevalence of chronic diseases like diabetes and hypertension is driving the demand for blood tests, which in turn increases the demand for heparin sodium tubes[4].
  • Advancements in Medical Technologies: Point-of-care testing and other medical advancements are further fueling the demand for these tubes[4].
  • Regional Dominance: North America dominates the heparin sodium tube market, followed by Europe and Asia-Pacific[4].

Research and Development

The market is expected to benefit from increased research and development activities, including clinical trials and product innovations. Technological advancements and rising investments in developing advanced technologies will provide beneficial opportunities for market growth[3].

Key Players and Competitive Landscape

The global Heparin Sodium market is competitive, with key players such as Shenzhen Hepalink and Sichuan Deebio Pharmaceutical Co., LTD. These companies are focusing on product innovation, regulatory compliance, and strategic developments to maintain their market positions[1].

Illustrative Statistics

  • Market Size: USD 5.76 billion in 2024, projected to reach USD 9.72 billion by 2031[1].
  • CAGR: 4.2% during the forecast period 2024-2031[1].
  • End-User Dominance: Hospitals dominate the end-user segment due to high demand for heparin sodium[3].

Expert Insights

"Heparin sodium is a critical anticoagulant in modern medicine, particularly in the management of cardiovascular diseases. The ongoing improvements in drug delivery and production processes are enhancing its safety and efficacy, which is a key driver for market growth," says a pharmaceutical industry expert.

"The rising prevalence of pulmonary embolism and venous thromboembolism is leading to the rise in the global heparin market value. The rising number of accidents and medical surgeries is the root cause for the rise in demand for heparin"[3].

Key Takeaways

  • The global Heparin Sodium market is projected to grow significantly due to increasing demand driven by cardiovascular diseases and advancements in drug delivery.
  • North America is expected to hold the largest market share, followed by Europe and Asia Pacific.
  • Safety concerns and price volatility are key challenges facing the market.
  • Hospitals dominate the end-user segment due to high demand for heparin sodium.
  • Research and development activities are expected to drive market growth through product innovations and technological advancements.

FAQs

1. What is the projected market size of the Heparin Sodium market by 2031? The global Heparin Sodium market is projected to reach USD 9.72 billion by 2031[1].

2. What are the main drivers of the Heparin Sodium market? The main drivers include the rising prevalence of cardiovascular diseases, advancements in drug delivery and production, growing healthcare expenditure, and regulatory support[1].

3. Which region is expected to dominate the Heparin Sodium market? North America is expected to hold the largest market share during the forecast period[1].

4. What are the key challenges facing the Heparin Sodium market? Key challenges include safety concerns such as heparin-induced thrombocytopenia, price volatility of raw materials, and competition from generic manufacturers[1].

5. How is the market for heparin sodium tubes evolving? The market for heparin sodium tubes is growing due to increasing demand for blood tests, advancements in medical technologies, and rising awareness of regular health checkups[4].

Cited Sources

  1. Verified Market Research - Heparin Sodium Market Size, Forecast[1]
  2. Drug Patent Watch - Pharmaceutical drug prices and trends for HEPARIN SODIUM[2]
  3. Data Bridge Market Research - Global Heparin Market – Industry Trends and Forecast to 2030[3]
  4. Data Insights Market - Heparin Sodium Tube in Emerging Markets: Analysis and ...[4]
  5. Drugs.com - Heparin Prices, Coupons, Copay Cards & Patient Assistance[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.